Breakthrough Gene Therapy at Primary Childrenâs Hospital helps little cowboy thrive
A rare, progressive genetic disease thatâs often fatal for infants and toddlers has been stopped its tracks by a groundbreaking gene therapy at Intermountain Primary Childrenâs Hospital.
By: Sponsored Content
and last updated 2021-02-11 10:35:47-05
A rare, progressive genetic disease thatâs often fatal for infants and toddlers has been stopped its tracks by a groundbreaking gene therapy at Intermountain Primary Childrenâs Hospital.
Primary Childrenâs was one of the first in the United States to offer the gene therapy Zolgensma, used to treat spinal muscular atrophy (SMA) in children younger than 2 years.
Intermountain Healthcare announced today a massive study conducted in partnership with deCODE genetics that invites children and families to voluntarily provide DNA samples to Intermountain Primary Children’s Hospital. Through its collection of 50,000 DNA samples, “HerediGene: Children’s Study” aims to utilize the DNA of children ranging from newborns to infants to help researchers discover cures for genetic disorders and to help children with these disorders access needed treatment.
According to Dr. Joshua Bonkowsky, professor of pediatrics at the University of Utah Health and director of the Primary Children’s Center for Personalized Medicine, the study the world’s largest DNA mapping endeavor for children ever done began in December but was officially announced to the public today. He says the study will have both short-term and long-term beneficial impacts for children with genetic disorders.
SALT LAKE CITY The number of patients at Primary Children s Hospital diagnosed with a coronavirus-related complication has doubled from the past two months.
In fact, there are now over 1,500 confirmed cases of multisystem inflammatory syndrome in children, otherwise known as MIS-C. The syndrome develops after the child has been infected by SARS-CoV-2.
As medical experts try to unravel the long-term effects of COVID-19, Primary Children s Hospital officials announced Tuesday that they will begin the first-term study of MIS-C.
The Long-Term Outcomes after the Multisystem Inflammatory Syndrome In Children, referred to as the MUSIC Study, will seek to answer how MIS-C affects children who were diagnosed five years after they developed it.
Utahâs Primary Childrenâs Hospital will help lead 5-year study of a mystery illness that strikes children who get COVID-19
Primary has seen more than 50 cases of MIS-C in children after they fought the coronavirus.
(Photo courtesy of Primary Children s Hospital) Madilyn Dayton stayed at Primary Children s Hospital after developing a condition called multisystem inflammatory syndrome in children. The illness appears in some children after they have had COVID-19. | Updated: 10:31 p.m.
Madilyn Dayton said she is mostly, but not entirely, recovered from the effects of a mysterious illness that strikes some children after they have had COVID-19.
âI still get tired a lot, easily,â Dayton, 13, said Tuesday from her home in Cokeville, Wyo. âOther than that, everything has gone almost back to normal.â
Despite the lack of snow, or because of it, sledding injuries have doubled in Utah this season and hospital officials are offering tips for parents to keep their children safe.